Manufacturing and Production

Showing 15 posts of 5881 posts found.

ceo_arnaud_lallouette

Servier UK appoints new chief executive

December 18, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Arnaud Lallouette, Mike Sumpter, Servier

Dr Arnaud Lallouette has been appointed chief executive of Servier Laboratories, the UK subsidiary of the French-based pharma firm, after …
tim-walbert

Horizon chief exec Walbert to head up US biotech trade body

December 18, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Illinois Biotechnology Industry Organisation, Timothy Walbert, iBio, illinois

Timothy Walbert, the chairman, president and chief executive of Horizon Pharma, has been elected as chairman of the board of …
Alliance Pharma logo

Alliance Pharma buys Sinclair’s healthcare products business for £132m

December 17, 2015 Manufacturing and Production, Sales and Marketing Alliance Pharma, Sinclair IS Pharma, acquisitions, dermatology merger

Alliance has completed a £132 million purchase of Sinclair IS Pharma’s non-aesthetics healthcare business as it moves to strengthen its …

AstraZeneca to acquire Takeda’s respiratory franchise

December 16, 2015 Manufacturing and Production, Research and Development AstraZeneca, China, Takeda, investment, respiratory

AstraZeneca and Takeda have agreed a multi-million pound deal for AZ to acquire the Japanese firm’s core respiratory business, including …
AZ Macclesfield site

AstraZeneca invests £75m to future-proof production facilities

December 15, 2015 Manufacturing and Production AstraZeneca, manufacturing, production

AstraZeneca says it will invest £75m to future-proof a key production facility in Macclesfield, Cheshire. The upgrade to the 48-year-old …
Sanofi BI logos

Pharma giants Sanofi and Boehringer negotiate deal to swap assets

December 15, 2015 Business Services, Manufacturing and Production, Sales and Marketing Andreas Barner, Boehringer, Boehringer Ingelheim, Merial, Sanofi, olivier brandicourt

Two of the world’s biggest pharma companies – Sanofi and Boehringer Ingelheim – have entered into exclusive negotiations to swap …
Malaria mosquito

GSK in malaria collaboration with Comic Relief

December 15, 2015 Manufacturing and Production Comic Relief, GSK, corporate social responsibility, csr, malaria

GSK and UK-based charity Comic Relief have launched a five-year partnership to fight malaria and improve health in five countries …

Bristol-Myers Squibb chooses UCLA as latest research partner

December 14, 2015 Manufacturing and Production, Research and Development BMS, Bristol-Myers Squibb, University of California Los Angeles, rare malignancies, ucla

Pharma firm Bristol-Myers Squibb is entered into a new collaboration agreement with the University of California Los Angeles (UCLA) as …
Ablynx CEO Edwin Moses

Ablynx sets focus on pharma collaborations

December 14, 2015 Manufacturing and Production, Research and Development Ablynx, collaboration, nanobodies, partnership

Drug development companies should prioritise strategic pharma collaborations to keep up with the next wave of immuno-oncology treatments, the chief …
personal-95715_640

Mirror. Signal. Merger. How to deal with a pharma takeover

December 14, 2015 Manufacturing and Production, Medical Communications, Sales and Marketing Deals, acquisition, buyouts, mergers, takeovers

So 2015 has been a record year for M&A in the pharma industry.The Financial Times has called this “the most …
Novolog pen

Novo Nordisk files for new insulin approval

December 10, 2015 Manufacturing and Production, Research and Development, Sales and Marketing FDA, NDA, Novo Nordisk, NovoLog, diabetes, insulin aspart, new drug application

Novo Nordisk has submitted a New Drug Application (NDA) for faster-acting insulin aspart to the FDA. If successful, the Danish …
sign-web

Daiichi Sankyo rocked by further job losses

December 9, 2015 Manufacturing and Production Daiichi, Daiichi Sankyo

The Japanese pharma firm Daiichi Sankyo is to close an antibody-producing subsidiary in Germany, as the company continues to cut …
Coartem dosing

Novartis reaches 300 million free antimalarial treatments

December 9, 2015 Manufacturing and Production, Research and Development Coartem, Novartis, antimalarial treatment, malaria, non-profit

Novartis has reached a delivery milestone of 300 million paediatric antimalarial treatments, having supplied its Coartem dispersible without profit to …
EMA inside

Sandoz announces biosimilar successes

December 8, 2015 Manufacturing and Production American Society of Hematology, Enbrel, Neulasta, Sandoz, ash, biosimilars, etanercept, pegfilgrastim

Novartis’ biosimilars division Sandoz has announced progress in its biosimilars programme, with its version of Amgen’s Neulasta proving as effective …
Lilly_labs_2

Lilly pulls plug on basal insulin Peglispro

December 8, 2015 Manufacturing and Production R&D, basal insulin peglispro, diabetes, lilly, peglispro, phase III failure

Lilly has decided to pull out of filing its diabetes drug basal insulin peglispro, after failing to convince regulators and …
The Gateway to Local Adoption Series

Latest content


Five Facts about COPD

October 11, 2026